ARCHIVES

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

Rare Lung Disease Raises Risk Of Meningiomas

October 26, 2001

In Brief: NSABP Selects 193 Institutions For STAR; ACR Names Evens, Ramsey As New Officers

October 9, 1998

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

July 17, 2009

DRCCA Concept Approvals; RFP For Evolution Of Three Programs; RFA For Cancer Care Of Elderly, New Physician Investigator Awards

October 29, 1982

Endoscopic Surgery Provides Equal Or Better Results

September 30, 2005

In Brief: New Spending Plan Funds NIH At FY95 Level; Continuing Resolution Expires Dec. 15

November 24, 1995